DFT-Enabled Development of Hemilabile (P ∧ N) Ligands for Gold(I/III) RedOx Catalysis: Application to the Thiotosylation of Aryl Iodides
Journal of the American Chemical Society · 14.02.2024 · 146 (6) · 3660-3674
DOI: 10.1021/jacs.3c08943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 05.02.2024. Verfasst von Karim Muratov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa K1N 6N5, Canada. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: University of Ottawa, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa K1N 6N5, Canada.
ORCID-Profile: Emil Zaripov, Maxim V Berezovski, Fabien Gagosz
Förderung
- University of Ottawa
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Muratov, K., Zaripov, E., Berezovski, M. V., & Gagosz, F. (2024). DFT-Enabled Development of Hemilabile (P ∧ N) Ligands for Gold(I/III) RedOx Catalysis: Application to the Thiotosylation of Aryl Iodides. Journal of the American Chemical Society, 146(6), 3660-3674. https://doi.org/10.1021/jacs.3c08943
Vancouver
Muratov K, Zaripov E, Berezovski MV, Gagosz F. DFT-Enabled Development of Hemilabile (P ∧ N) Ligands for Gold(I/III) RedOx Catalysis: Application to the Thiotosylation of Aryl Iodides. Journal of the American Chemical Society. 2024;146(6):3660-3674. doi:10.1021/jacs.3c08943
BibTeX
@article{Muratov2024,
author = {Muratov, Karim and Zaripov, Emil and Berezovski, Maxim V and Gagosz, Fabien},
title = {DFT-Enabled Development of Hemilabile (P ∧ N) Ligands for Gold(I/III) RedOx Catalysis: Application to the Thiotosylation of Aryl Iodides},
journal = {Journal of the American Chemical Society},
year = {2024},
volume = {146},
number = {6},
pages = {3660--3674},
doi = {10.1021/jacs.3c08943}
}
EUVIMED